Literature DB >> 28166330

Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.

R H Goldman1, C Racowsky1, L V Farland1, S Munné2, L Ribustello2, J H Fox1.   

Abstract

Study question: Can a counseling tool be developed for women desiring elective oocyte cryopreservation to predict the likelihood of live birth based on age and number of oocytes frozen? Summary answer: Using data from ICSI cycles of a population of women with uncompromised ovarian reserve, an evidence-based counseling tool was created to guide women and their physicians regarding the number of oocytes needed to freeze for future family-building goals. What is known already: Elective oocyte cryopreservation is increasing in popularity as more women delay family building. By undertaking elective oocyte freezing at a younger age, women hope to optimize their likelihood of successful live birth(s) using their thawed oocytes at a future date. Questions often arise in clinical practice regarding the number of cryopreserved oocytes sufficient to achieve live birth(s) and whether or not additional stimulation cycles are likely to result in a meaningful increase in the likelihood of live birth. As relatively few women who have electively cryopreserved oocytes have returned to use them, available data for counseling patients wishing to undergo fertility preservation are limited. Study design, size, duration: A model was developed to determine the proportion of mature oocytes that fertilize and then form blastocysts as a function of age, using women with presumably normal ovarian reserve based on standard testing who underwent ICSI cycles in our program from January, 2011 through March, 2015 (n = 520). These included couples diagnosed exclusively with male-factor and/or tubal-factor infertility, as well as cycles utilizing egg donation. Age-specific probabilities of euploidy were estimated from 14 500 PGS embryo results from an external testing laboratory. Assuming survival of thawed oocytes at 95% for women <36 y and for egg donors, and 85% for women ≥36 y, and 60% live birth rate per transferred euploid blastocyst, probabilities of having at least one, two or three live birth(s) were calculated. Participants/materials, setting, method: First fresh male-factor and/or tubal-factor only autologous ICSI cycles (n = 466) were analyzed using Poisson regression to calculate the probability that a mature oocyte will become a blastocyst based on age. Egg donation cycles (n = 54) were analyzed and incorporated into the model separately. The proportion of blastocysts expected to be euploid was determined using PGS results of embryos analyzed via array comparative genomic hybridization. A counseling tool was developed to predict the likelihood of live birth, based on individual patient age and number of mature oocytes. Main results and the role of chance: This study provides an evidence-based model to predict the probability of a woman having at least one, two or three live birth(s) based on her age at egg retrieval and the number of mature oocytes frozen. The model is derived from a surrogate population of ICSI patients with uncompromised ovarian reserve. A user-friendly counseling tool was designed using the model to help guide physicians and patients. LIMITATIONS, REASONS FOR CAUTION: The data used to develop the prediction model are, of necessity, retrospective and not based on patients who have returned to use their cryopreserved oocytes. The assumptions used to create the model, albeit reasonable and data-driven, vary by study and will likely vary by center. Centers are therefore encouraged to consider their own blastocyst formation and thaw survival rates when counseling patients. Limitations, reasons for caution: Our model will provide a counseling resource that may help inform women desiring elective fertility preservation regarding their likelihood of live birth(s), how many cycles to undergo, and when additional cycles would bring diminishing returns. Study funding/competing interests: None. Trial registration number: Not applicable.
© The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  blastocyst euploidy; blastocyst formation; egg thaw; elective egg freezing; family building; fertility preservation; oocyte cryopreservation; prediction model

Mesh:

Year:  2017        PMID: 28166330     DOI: 10.1093/humrep/dex008

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  26 in total

1.  From artefactual to artificial intelligence-meeting the needs of ART patients and practitioners.

Authors:  David F Albertini
Journal:  J Assist Reprod Genet       Date:  2018-09       Impact factor: 3.412

2.  Oocyte cryopreservation in two women with borderline ovarian tumor recurrence.

Authors:  Francesca Filippi; Fabio Martinelli; Edgardo Somigliana; Dorella Franchi; Francesco Raspagliesi; Valentina Chiappa
Journal:  J Assist Reprod Genet       Date:  2020-03-04       Impact factor: 3.412

3.  Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield.

Authors:  Kaitlyn Wald; Hakan Cakmak; Evelyn Mok-Lin; Marcelle Cedars; Mitchell Rosen; Joseph Letourneau
Journal:  J Assist Reprod Genet       Date:  2019-05-24       Impact factor: 3.412

4.  Elective egg freezing for age-related fertility decline.

Authors:  Jenna Gale; Aisling A Clancy; Paul Claman
Journal:  CMAJ       Date:  2020-02-10       Impact factor: 8.262

5.  Likelihood of achieving a 50%, 60%, or 70% estimated live birth rate threshold with 1 or 2 cycles of planned oocyte cryopreservation.

Authors:  Bat-Sheva L Maslow; Michael M Guarnaccia; Leslie Ramirez; Joshua U Klein
Journal:  J Assist Reprod Genet       Date:  2020-05-16       Impact factor: 3.412

6.  Fertility-related experiences after breast cancer diagnosis in the Sister and Two Sister Studies.

Authors:  Leah Hawkins Bressler; Jennifer E Mersereau; Chelsea Anderson; Juan L Rodriguez; M Elizabeth Hodgson; Clarice R Weinberg; Dale P Sandler; Hazel B Nichols
Journal:  Cancer       Date:  2019-04-23       Impact factor: 6.860

7.  More than the oocyte source, egg donors as patients: a national picture of United States egg donors.

Authors:  Jennifer F Kawwass; Patrick Ten Eyck; Patrick Sieber; Heather S Hipp; Brad Van Voorhis
Journal:  J Assist Reprod Genet       Date:  2021-04-01       Impact factor: 3.412

8.  Predicting the Likelihood of Live Birth in Assisted Reproductive Technology According to the Number of Oocytes Retrieved and Female Age Using a Generalized Additive Model: A Retrospective Cohort Analysis of 17,948 Cycles.

Authors:  Haiyan Zhu; Chenqiong Zhao; Peiwen Xiao; Songying Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-30       Impact factor: 5.555

9.  Preservation of female fertility in humans and animal species.

Authors:  Helen Mary Picton
Journal:  Anim Reprod       Date:  2018-08-17       Impact factor: 1.807

10.  Chromosomal Analysis of Cumulus Cells as a Future Predictor for Oocyte Aneuploidy: A Case Report.

Authors:  Xavier Viñals Gonzalez; Rabi Ahmed-Odia; Sioban Sen Gupta; Roy Pascal Naja; Falak Arshad; Paul Serhal; Wael Saab; Srividya Seshadri
Journal:  J Reprod Infertil       Date:  2021 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.